Allergy, Immunology, and ENT

Latest News

Pediatric FDA, clinical trial, and interview recap from Q1 2025 | Image Credit: © Araki Illustrations - © Araki Illustrations  - stock.adobe.com.
Q1 2025: A recap of the top headlines and interviews

April 3rd 2025

View our Q1 2025 recap of standout pediatric news from FDA regulatory updates, clinical trial results, and expert commentary.

Anaphylm (Photo courtesy of Aquestive Therapeutics.)
Anaphylm sublingual film demonstrates positive results in pediatric patients with severe allergic reactions

April 1st 2025

FDA news in pedatrics: March 2025 | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.
FDA news in pedatrics: March 2025

April 1st 2025

Image Credit: © Татьяна Креминская - stock.adobe.com.
Omalizumab outperforms oral immunotherapy in treating multi-food allergy

March 27th 2025

Jay Rubinstein, MD, PhD, explains DB-OTO gene therapy in children with profound hearing loss
Jay Rubinstein, MD, PhD, explains DB-OTO gene therapy in children with profound hearing loss

March 7th 2025

More News


Site Logo

Wheeze in Preschool Children:

April 1st 2007

Severe disability and even death can result from the inappropriate diagnosis and treatment of a young child's wheezing, which is heterogeneous in its origins and expression. Consequently, a differential diagnosis is necessary to determine the cause and to develop an effective management strategy. Viral-induced wheeze, especially from respiratory syncytial virus (RSV), manifests as a bronchiolitis. Recent reports show that the cysteinyl leukotrienes are an important mediator of the airway effects of RSV infection and that leukotriene receptor antagonists reduce postrespiratory syncytial virus lung symptoms. Exercise-induced bronchoconstriction manifests as wheezing and can be treated or pretreated short-term with inhaled bronchodilators or cromolyn: long-term therapy includes inhaled corticosteroids and leukotriene receptor antagonists. Allergic rhinitis-associated wheeze may be the result of acute exposure to an allergen or simply from nasal dysfunction. Control of allergic rhinitis with intranasal steroids, antihistamines, or leukotriene receptor antagonists could relieve the wheezing. Asthma-associated wheeze requires long-term use of 1 or more daily controller medications. The primary goal is to navigate the child safely through the first episode of wheezing, consider the causes of the wheeze, and then evaluate the need for further therapy. All apparent causes of wheeze should be treated with the idea that if the apparent cause turns out not to be the actual cause, treatment can be safely discontinued.

© 2025 MJH Life Sciences

All rights reserved.